Cargando…

Significant Decrease in the Prevalence of Anxiety and Depression after Hepatitis C Eradication

Chronic hepatitis C (CHC) is an ongoing epidemiological problem. The hepatitis C virus (HCV) may infect brain tissue, worsening mental health outcomes. The new era of highly effective oral Direct-Acting Agents (DAA) has brought a chance to eradicate the infection by 2030, however, screening campaign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slonka, Justyna, Piotrowski, Damian, Janczewska, Ewa, Pisula, Arkadiusz, Musialik, Joanna, Jaroszewicz, Jerzy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181745/ https://www.ncbi.nlm.nih.gov/pubmed/35683432 http://dx.doi.org/10.3390/jcm11113044

Ejemplares similares

Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis: A Multicenter Cohort Study
por: Janczewska, Ewa, et al.
Publicado: (2015)

Predictive power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score for mortality in cirrhotic patients
por: Piotrowski, Damian, et al.
Publicado: (2018)

Lymphocyte-To-Monocyte Ratio as the Best Simple Predictor of Bacterial Infection in Patients with Liver Cirrhosis
por: Piotrowski, Damian, et al.
Publicado: (2020)

The Role of Illness-Related Beliefs in Depressive, Anxiety, and Anger Symptoms: An On-line Survey in Women With Hypothyroidism
por: Pankowski, Daniel, et al.
Publicado: (2021)

Hepatitis C eradication with sofosbuvir leads to significant metabolic changes
por: Morales, Amilcar L, et al.
Publicado: (2016)

Chronic hepatitis B virus infection is associated with decreased serum 25(OH)D concentration in non-cirrhotic patients
por: Parfieniuk-Kowerda, Anna, et al.
Publicado: (2019)

Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C – a real-world study
por: Simon, Krzysztof Adam, et al.
Publicado: (2019)

Real-World Effectiveness and Safety of Direct-Acting Antivirals in Patients with Chronic Hepatitis C and Epilepsy: An Epi-Ter-2 Study in Poland
por: Pazgan-Simon, Monika, et al.
Publicado: (2023)

Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy
por: Stawicka, Agnieszka, et al.
Publicado: (2020)

Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections—Upper Silesia pilot study
por: Mika, Justyna, et al.
Publicado: (2021)

Brain-derived neurotrophic factor as a potential diagnostic marker in minimal hepatic encephalopathy
por: Stawicka, Agnieszka, et al.
Publicado: (2021)

Antifungal Drug-Drug Interactions with Commonly Used Pharmaceutics in European Pediatric Patients with Acute Lymphoblastic Leukemia
por: Sienkiewicz-Oleszkiewicz, Beata, et al.
Publicado: (2023)

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2019)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals
por: Flisiak, Robert, et al.
Publicado: (2023)

Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C
por: Rogalska-Taranta, Magdalena, et al.
Publicado: (2017)

Types of Anxiety and Depression: Theoretical Assumptions and Development of the Anxiety and Depression Questionnaire
por: Fajkowska, Małgorzata, et al.
Publicado: (2018)

Immune regulation and viral diversity as correlates of natural and treatment induced immune control in persistent hepatitis B virus (HBV) infection
por: Parfieniuk-Kowerda, Anna, et al.
Publicado: (2015)

Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
por: Pawłowska, Małgorzata, et al.
Publicado: (2019)

Hepatitis C Treatment and Barriers to Eradication
por: Konerman, Monica A, et al.
Publicado: (2016)

Towards the elimination and eradication of hepatitis B
por: Dusheiko, Geoffrey
Publicado: (2015)

Significant Association Between Huntingtin Gene Mutation and Prevalence of Hopelessness, Depression and Anxiety Symptoms
por: Butėnaitė, Adelė, et al.
Publicado: (2021)

COVID-19-related social isolation and symptoms of depression and anxiety in young men in Poland: Does insomnia mediate the relationship?
por: Mojsa-Kaja, Justyna, et al.
Publicado: (2023)

Polymicrobial Infections and Biofilms: Clinical Significance and Eradication Strategies
por: Anju, V T, et al.
Publicado: (2022)

SUN-201 Depression and Anxiety Decreases among Females with Premenstrual Syndrome
por: Seidel, Vinicius, et al.
Publicado: (2019)

The Relationship between Temperament and Autistic Traits in a Non-Clinical Students Sample
por: Pisula, Ewa, et al.
Publicado: (2015)

Autism spectrum quotient, coping with stress and quality of life in a non-clinical sample – an exploratory report
por: Pisula, Ewa, et al.
Publicado: (2015)

Prevalence of HCV genotypes in Poland – the EpiTer study
por: Flisiak, Robert, et al.
Publicado: (2016)

What happens after hepatitis C eradication?
por: Pol, Stanislas
Publicado: (2012)

The Challenging Road to Hepatitis C Virus Eradication
por: Martínez, Isidoro, et al.
Publicado: (2021)

Changes in Office Blood Pressure Control, Augmentation Index, and Liver Steatosis in Kidney Transplant Patients after Successful Hepatitis C Infection Treatment with Direct Antiviral Agents
por: Kolonko, Aureliusz, et al.
Publicado: (2020)

Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease
por: Majewski, Sebastian, et al.
Publicado: (2019)

Prenatal and Postnatal Anxiety and Depression in Mothers during the COVID-19 Pandemic
por: Baran, Joanna, et al.
Publicado: (2021)

Insulin resistance and its consequences in chronic hepatitis C
por: Kukla, Michał, et al.
Publicado: (2015)

Review: Serum Biomarkers of Lung Fibrosis in Interstitial Pneumonia with Autoimmune Features—What Do We Already Know?
por: Miądlikowska, Ewa, et al.
Publicado: (2021)

CONTEXTUAL FACTORS ASSOCIATED WITH DECREASED DAILY DEPRESSION AND ANXIETY AMONG DEMENTIA CAREGIVERS
por: Puga, Frank, et al.
Publicado: (2022)

Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates
por: Huh, Cheal Wung, et al.
Publicado: (2016)

High prevalence of anti-HEV antibodies among patients with immunosuppression and hepatic disorders in eastern Poland
por: Parfieniuk-Kowerda, Anna, et al.
Publicado: (2018)

Adaptation and Validation of the ADOS-2, Polish Version
por: Chojnicka, Izabela, et al.
Publicado: (2017)

Service use, unmet needs, and barriers to services among adolescents and young adults with autism spectrum disorder in Poland
por: Płatos, Mateusz, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2lc8be0f2uvrvrb3q5e1tf4gmi